New PDE4 Inhibitors Show Promise in Psoriasis Treatment
Patients with psoriasis have a new treatment option on the horizon, as second-generation phosphodiesterase 4 (PDE4) inhibitors show promising results in clinical trials. Currently, apremilast is the established PDE4 inhibitor…